Works matching IS 03618609 AND DT 2022 AND VI 97 AND IP 11
Results: 30
Hodgkin lymphoma: 2023 update on diagnosis, risk‐stratification, and management.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1478, doi. 10.1002/ajh.26717
- Publication type:
- Article
Efficacy of pp65‐specific TCR‐T cell therapy in treating cytomegalovirus infection after hematopoietic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1453, doi. 10.1002/ajh.26708
- By:
- Publication type:
- Article
Use of CYP3Ai and impact on outcomes in patients with acute myeloid leukemia treated with venetoclax plus azacitidine in the VIALE‐A study.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. E422, doi. 10.1002/ajh.26707
- By:
- Publication type:
- Article
A roadmap for clinical trial design in marginal zone lymphoma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1398, doi. 10.1002/ajh.26706
- By:
- Publication type:
- Article
The prevalence and clinical outcomes of microangiopathic hemolytic anemia in patients with biopsy‐proven renal thrombotic microangiopathy.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. E426, doi. 10.1002/ajh.26705
- By:
- Publication type:
- Article
HbSC disease: A time for progress.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1390, doi. 10.1002/ajh.26702
- By:
- Publication type:
- Article
Hematological support of patients with significant anemia who decline red blood cell blood transfusion.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. E430, doi. 10.1002/ajh.26701
- By:
- Publication type:
- Article
Retrospective comparison of survival and responses to Fludarabine, Cytarabine, GCSF (FLAG) in combination with gemtuzumab ozogamicin (GO) or Idarubicin (IDA) in patients with newly diagnosed core binding factor (CBF) acute myelogenous leukemia: MD Anderson experience in 174 patients
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1427, doi. 10.1002/ajh.26700
- By:
- Publication type:
- Article
Converting adults with sickle cell disease from full agonist opioids to buprenorphine: A reliable method with safety and early evidence of reduced acute care utilization.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1435, doi. 10.1002/ajh.26699
- By:
- Publication type:
- Article
Postremission cytopenia management in patients with acute myeloid leukemia treated with venetoclax and azacitidine in VIALE‐A.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. E416, doi. 10.1002/ajh.26692
- By:
- Publication type:
- Article
Adoptive transfer of functional SARS‐COV‐2‐specific immunity from donor graft to hematopoietic stem cell transplant recipients.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. E404, doi. 10.1002/ajh.26691
- By:
- Publication type:
- Article
Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD‐negative remission.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. E408, doi. 10.1002/ajh.26698
- By:
- Publication type:
- Article
Tyrosine kinase inhibitors dosing for chronic phase chronic myeloid leukemia: The case for starting low with dasatinib (50 mg/day) and ponatinib (15 mg/day).
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1394, doi. 10.1002/ajh.26695
- By:
- Publication type:
- Article
Contemporary outcomes in IDH‐mutated acute myeloid leukemia: The impact of co‐occurring NPM1 mutations and venetoclax‐based treatment.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1443, doi. 10.1002/ajh.26694
- By:
- Publication type:
- Article
Caplacizumab for congenital thrombotic thrombocytopenic purpura.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. E420, doi. 10.1002/ajh.26693
- By:
- Publication type:
- Article
A common pattern of somatic mutations in t‐MDS/AML of patients treated with PARP inhibitors for metastatic ovarian cancer.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. E400, doi. 10.1002/ajh.26697
- By:
- Publication type:
- Article
Adherence to NHLBI guidelines for the emergent management of vaso‐occlusive episodes in children with sickle cell disease: A multicenter perspective.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. E412, doi. 10.1002/ajh.26696
- By:
- Publication type:
- Article
Erythrocytic vacuoles that accumulate a fluorescent dye predict spleen size and function in sickle cell disease.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. E385, doi. 10.1002/ajh.26690
- By:
- Publication type:
- Article
Low‐dose dasatinib 50 mg/day versus standard‐dose dasatinib 100 mg/day as frontline therapy in chronic myeloid leukemia in chronic phase: A propensity score analysis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1413, doi. 10.1002/ajh.26689
- By:
- Publication type:
- Article
Co‐expression of mutated Jak2 and Calr enhances myeloproliferative phenotype in mice without loss of stem cell fitness.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. E396, doi. 10.1002/ajh.26688
- By:
- Publication type:
- Article
Homozygosity for the hyperunstable hemoglobin variant Hb Agrinio (HBA2:c.89T>C) leads to severe antenatal anemia: Eight new cases in three families.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. E393, doi. 10.1002/ajh.26687
- By:
- Publication type:
- Article
Innovative strategies to improve hematopoietic stem cell transplant outcomes in myelofibrosis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1464, doi. 10.1002/ajh.26654
- By:
- Publication type:
- Article
Thirteen‐month‐old girl with hyporegenerative macrocytic anemia due to Brown–Vialetto–Van Laere syndrome 2.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1495, doi. 10.1002/ajh.26573
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1387, doi. 10.1002/ajh.26228
- Publication type:
- Article
Ponatinib after failure of second‐generation tyrosine kinase inhibitor in resistant chronic‐phase chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1419, doi. 10.1002/ajh.26686
- By:
- Publication type:
- Article
A case of chronic neutrophilic leukemia and multiple myeloma showing the benefits of lenalidomide and cyclophosphamide therapy in treating both conditions.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1491, doi. 10.1002/ajh.26670
- By:
- Publication type:
- Article
Peripheral CD5+ CD10+ B‐cell proliferation with atypical morphology attributable to human herpesvirus 6 infection following umbilical cord blood transplantation.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1489, doi. 10.1002/ajh.26655
- By:
- Publication type:
- Article
Frequent bleeding symptoms associated with autoimmune acquired factor XIII/13 deficiency due to anti‐factor XIII A and B subunit antibodies.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1497, doi. 10.1002/ajh.26685
- By:
- Publication type:
- Article
Single‐molecule real‐time sequencing of the M protein: Toward personalized medicine in monoclonal gammopathies.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. E389, doi. 10.1002/ajh.26684
- By:
- Publication type:
- Article
The role of hypoxia and inflammation in the regulation of iron metabolism and erythropoiesis in COVID‐19: The IRONCOVID study.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1404, doi. 10.1002/ajh.26679
- By:
- Publication type:
- Article